IMMUNODIRECTABLE MR CONTRAST AGENTS

Information

  • Research Project
  • 3491851
  • ApplicationId
    3491851
  • Core Project Number
    R43CA045910
  • Full Project Number
    1R43CA045910-01
  • Serial Number
    45910
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/1987 - 37 years ago
  • Project End Date
    2/29/1988 - 36 years ago
  • Program Officer Name
  • Budget Start Date
    9/15/1987 - 37 years ago
  • Budget End Date
    2/29/1988 - 36 years ago
  • Fiscal Year
    1987
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/9/1987 - 37 years ago
Organizations

IMMUNODIRECTABLE MR CONTRAST AGENTS

A number of syntheses of small magnetic particles permitting the covalent attachment of antibodies will be examined. Changes in magnetic resonance (MR) proton relaxation after magnetic antibodies have bound to cell surface antigens will be utilized to demonstrate the binding of antibody (and magnetic label) to antigens. The magnetic labels investigated will possess the magnetic properties of a crystal (e.g. high magnetic susceptibility), but possess the solution properties of soluble micromolecules (e.g. no setting on prolonged standing). One advantage of attaching antibody to magnetic particles, over the often used approach of derivatizing proteins with chelators, is that far more metal ions can be attached per mole of antibody. Highly magnetic proteins maybe useful agents for immunodirectable MR contrast agents. Key words: image enhancement, contrast agents, magnetic resonance Summary of Potential Commercial Application: The proposed research will lead to the development of a new class of magnetic labels to which antibodies can be attached. The magnetic labels will serve as immunodirectable MR image contrast agents. Immunospecific methods of tumor localization have long been of major research and commercial interest. Unlike radiolabelled antibodies, magnetic labels show no radioactive decay. Centralized manufacture of magnetically labelled antibodies for tumor localization will become possible.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    ADVANCED MAGNETICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02138
  • Organization District
    UNITED STATES